Also from LL-37 fragments, changing the end or one amino acid may give different results. A 2026 study compared two modified peptides, measuring both inhibitory concentration and checking whether the bacterial outer layer was affected.
What was tested was a modified fragment, not the complete LL-37
The study compared LL37-1 with D-LL37. The former is a truncated peptide with terminal amidation, while the latter also involves terminal acetylation and one D-type amino acid substitution.
D-type and common L-type amino acids can be simply understood as different spatial forms. Changing only one position may also affect peptide stability and interactions. Therefore, experimental materials need to be confirmed by specific structure.
What does IC50 mean?
IC50 is the concentration required to achieve 50% inhibition. Under the same experimental conditions, a lower value means a lower material concentration is needed to reach this inhibition level.[1]
The IC50 of D-LL37 is about 10.11 micromolar, and that of LL37-1 is about 15.45 micromolar. The IC90 values are about 18.40 and 25.44 micromolar respectively. What is compared here is the inhibitory concentration under culture conditions, not a human therapeutic dose.
How were outer membrane changes observed?
The authors used fluorescence-related assays and scanning electron microscopy to observe permeability and bacterial morphology. They support that the two peptides are related to outer structure disturbance, but the membrane damage shown by the assays does not mean that “all bacteria were completely broken apart.”[1]
Growth inhibition and membrane structure changes are two types of results. Looking at them together helps explain the process of action; it is still necessary to check whether there are other mechanisms.
Bacterial stress responses also provide clues
After D-LL37 treatment, the expression of some genes related to ion transport increased. This can be seen as a response in which bacteria adjust their internal work when facing environmental changes.
Gene expression changes help researchers propose mechanisms, but an increase in a certain gene alone cannot be used to claim that it is the only target or that the drug resistance problem has been solved.
What must be crossed to go from culture experiments to treatment?
It is still necessary to study effects on host cells, stability in complex environments, whether it can reach the infection site, and safety and efficacy in animals and humans. Concentrations in culture medium cannot be directly copied.
The most practical inspiration from this paper is: terminal form and a single amino acid may both change the results. When purchasing or reproducing, only writing “LL-37” is far from enough.
If IC50 is low, can it be said to be safer?
No. The concentration needed to inhibit bacteria and the concentration that harms host cells are two types of tests. Only by looking at them together is it easier to judge whether a candidate material has a range suitable for further research.
When comparing fragments, it should also be confirmed that concentration units, terminal modifications, purity, and salt form are consistent. If these conditions differ greatly, the results may be affected by multiple factors at the same time.
View materials and analytical information
The LL-37 catalog page provides parent peptide information; if studying LL37-1 or D-LL37, the sequence, D-type position, and terminal modifications should be checked item by item through customized services.
LL-37
Check the parent peptide and modified fragment separately, and confirm sequence and termini.
Custom peptide service
Explain the required sequence, terminal form, quantity, and testing requirements, and confirm the delivery scope according to the project.
Original materials
Sources & editorial method
AI-assisted writing
1 linked records are listed in the references below. Read the editorial and AI-assistance policy.
How to interpret this article
Original public sources, study populations and limitations are linked. Editorial illustrations are not experimental photographs.
Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.
Primary records and authoritative sources
Continue with structured records
Move from this editorial analysis to the product identity, filtered evidence and controlled terminology behind it.
